MDLN

Medline Inc. Class A Common Stock (MDLN) | Rumor.io

Medline

MDLN

Attention (50-day avg)0%

Attention rank (50-day avg)#1,079

Bullish sentiment (50-day avg)100%

Price to earnings ratio43.4

Market capitalization47.2B

Earnings per share0.8

Dividend yield (TTM)—

Revenue (annual)28.4B

Net income (annual)1.2B

Social

What share of all stock conversation is about MDLN?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% 0	0% new

Aug 5

Medline Inc. reported Q2 2026 earnings, with revenue of $7.69B, a 11.6% YoY increase, and adjusted EBITDA of $1.06B, a 13.4% YoY increase.
Net income fell 58.3% to $139M due to a $336M distribution center fire loss and tariff pressure, despite strong sales.
Medline cut full-year 2026 adjusted EBITDA guidance to $3.3B-$3.4B from $3.5B-$3.6B, citing inflation, quality remediation costs, and retail channel softness.

Generated by AI

Sentiment

Of the messages about MDLN that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	100%	100% +0.34	96.65%
Bearish	—	0%	0% -0.34	3.35%

Dec 17

The company has a strong professional reputation, with a history of long-lasting partnerships and a financially healthy business model.
Medline's essential medical equipment products are likely to drive long-term growth, making it a worthwhile investment.
The company's successful IPO and strong first trading day suggest a promising future, with potential for significant increases in value.

Generated by AI

Topics

Of the messages about MDLN that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	64.52%	1.95%
Analysts	—	—	17.74%	42.89%
Macro	—	—	17.74%	42.73%
Earnings	—	—	0%	6.16%
Technical Analysis	—	—	0%	6.26%
Controversies	—	—	0%	0%

Community

Of the messages about MDLN, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	27.27%	15.95%	0.34%
Newcomers	100%	72.73%	84.05%	99.66%

Aug 5

Medline Inc. ($34.2B) has reported Q2 2026 earnings, beating estimates with total revenue of $7.69B (vs. $7.51B forecast) and adjusted EPS of $0.50 (vs. $0.32 estimate).
The company's net income fell 58.3% to $139M due to the Tracy fire and tariff pressure, despite adjusted EBITDA rising 13.4% to $1.06B.
Medline has updated its full-year 2026 outlook, reducing adjusted EBITDA guidance to $3.3B-$3.4B, citing Middle East conflict inflation, quality remediation costs, and retail channel softness.

Generated by AI

Medline (MDLN) is drawing investor attention after a recent share price pullback, with the stock down about 7% over the past month and roughly 9% over the past 3 months. Over a longer stretch, the share price return tells a similar story, with Medline down about 22% year to date. This indicates that momentum has been fading as investors reassess both the company’s growth outlook and the risks they are willing to price into the stock. Compare Medline's recent pullback with a curated 35 high...

10d agoYahoo Finance

Medline (MDLN) Stock Could Trade Below Fair Value As Shares Fell 22%

Medline shares have fallen sharply this year, which puts the spotlight squarely on whether the current US$31.64 price is still aligned with the cash the business is expected to generate. With a Discounted Cash Flow (DCF) intrinsic value estimate available, the central question is how that cash flow outlook lines up with the market’s reset expectations. The stock is down 22.1% year to date, so the market has already repriced Medline and raised fresh questions about what its future cash...

10d agoYahoo Finance

Medline: A Tough First Year As A Public Business (NASDAQ:MDLN)

13d agoSeeking Alpha

Medline (MDLN) Slips Amid Broader MedTech Weakness

Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” second-quarter 2026 investor letter. The letter can be downloaded here. During the quarter, the Fund (Investor Shares) returned 17.49% (net of fees), outperforming the Russell 1000 Growth Index’s 16.74%. Holdings in Information Technology and Consumer Discretionary sectors boosted relative returns, while Communication Services […]

13d agoYahoo Finance

Kaplan Fox is Investigating Medline Inc. (NASDAQ: MDLN) for Potential Securities Law Violations - Investors are Encouraged to Contact the Firm

14d agoBarchart.com

Also Discussed

Investors talking about MDLN also mention

#	Name	Attention
1	Figma Inc. Class A Common StockFIG	0.02%-0.01
2	Fermi Inc.FRMI	0.01%+0
3	AMC Robotics CorporationAMCI	0%0
4	cbdMD Inc.YCBD	0%new
5	Corteva Inc.CTVA	0%0
6	Qxo Inc.QXO	0.02%+0.01
7	CoreWeave, Inc. Class A Common StockCRWV	0.24%-0.37
8	Tempus AI Inc Class A Common StockTEM	0%-0.11
9	Mawson Infrastructure Group Inc.MIGI	0%0
10	Rockwell Automation Inc.ROK	0%0

Medline Inc. Class A Common Stock

Healthcare
Medical Instruments & Supplies

Medline Inc. Class A Common Stock represents ownership in Medline Inc., a healthcare company focused on medical-surgical products and supply chain solutions. Medline serves hospitals, ambulatory surgery centers, physician offices, post-acute facilities, and nursing homes through a broad portfolio of products and services used across everyday clinical care. Its business is organized around product manufacturing and procurement, as well as logistics and distribution support for healthcare customers. The company also provides tailored supply chain solutions designed to help healthcare providers manage sourcing, inventory, and delivery across multiple care settings. Medline’s role in the market is centered on supporting the operational needs of the healthcare industry with essential supplies and integrated services.

Website

Location

3 Lakes Drive

Northfield, IL, 60093

United States

Social

What share of all stock conversation is about MDLN?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% 0	0% new

Aug 5

Medline Inc. reported Q2 2026 earnings, with revenue of $7.69B, a 11.6% YoY increase, and adjusted EBITDA of $1.06B, a 13.4% YoY increase.
Net income fell 58.3% to $139M due to a $336M distribution center fire loss and tariff pressure, despite strong sales.
Medline cut full-year 2026 adjusted EBITDA guidance to $3.3B-$3.4B from $3.5B-$3.6B, citing inflation, quality remediation costs, and retail channel softness.

Generated by AI

Sentiment

Of the messages about MDLN that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	100%	100% +0.34	96.65%
Bearish	—	0%	0% -0.34	3.35%

Dec 17

The company has a strong professional reputation, with a history of long-lasting partnerships and a financially healthy business model.
Medline's essential medical equipment products are likely to drive long-term growth, making it a worthwhile investment.
The company's successful IPO and strong first trading day suggest a promising future, with potential for significant increases in value.

Generated by AI

Topics

Of the messages about MDLN that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	64.52%	1.95%
Analysts	—	—	17.74%	42.89%
Macro	—	—	17.74%	42.73%
Earnings	—	—	0%	6.16%
Technical Analysis	—	—	0%	6.26%
Controversies	—	—	0%	0%

Community

Of the messages about MDLN, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	27.27%	15.95%	0.34%
Newcomers	100%	72.73%	84.05%	99.66%

Aug 5

Medline Inc. ($34.2B) has reported Q2 2026 earnings, beating estimates with total revenue of $7.69B (vs. $7.51B forecast) and adjusted EPS of $0.50 (vs. $0.32 estimate).
The company's net income fell 58.3% to $139M due to the Tracy fire and tariff pressure, despite adjusted EBITDA rising 13.4% to $1.06B.
Medline has updated its full-year 2026 outlook, reducing adjusted EBITDA guidance to $3.3B-$3.4B, citing Middle East conflict inflation, quality remediation costs, and retail channel softness.

Generated by AI

Medline

Social

Aug 5

Sentiment

Dec 17

Topics

Community

Aug 5

News

Why is Medline stock rallying today?

Medline (MDLN) Could Be 29% Undervalued As Its Pullback Tests Sentiment

Medline (MDLN) Stock Could Trade Below Fair Value As Shares Fell 22%

Medline: A Tough First Year As A Public Business (NASDAQ:MDLN)

Medline (MDLN) Slips Amid Broader MedTech Weakness

Kaplan Fox is Investigating Medline Inc. (NASDAQ: MDLN) for Potential Securities Law Violations - Investors are Encouraged to Contact the Firm

Also Discussed

Medline Inc. Class A Common Stock

Company Information

Location

News

Why is Medline stock rallying today?

Medline (MDLN) Could Be 29% Undervalued As Its Pullback Tests Sentiment

Medline (MDLN) Stock Could Trade Below Fair Value As Shares Fell 22%

Medline: A Tough First Year As A Public Business (NASDAQ:MDLN)

Medline (MDLN) Slips Amid Broader MedTech Weakness

Kaplan Fox is Investigating Medline Inc. (NASDAQ: MDLN) for Potential Securities Law Violations - Investors are Encouraged to Contact the Firm

Also Discussed

Social

Aug 5

Sentiment

Dec 17

Topics

Community

Aug 5